Skip to content

Orthofix Medical Inc. OFIX Additional Paid-In Capital

Additional Paid-In Capital at other companies

Stryker logo
StrykerSYK
$2.65B+8.5%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$239.47M+10.3%
Artivion logo
ArtivionAORT
$526.26M+35.3%
IAR
Integra LifeSciencesIART
$1.34B+1.3%
Boston Scientific logo
Boston ScientificBSX
$21.58B+2.2%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH

Other financials

Income statement

See full
Revenue$196.7M+1.6%
Gross profit$139.5M+14.7%
Operating income-$14.4M+70.5%
Net income-$20.9M+60.6%
EPS (diluted)-$0.52+61.5%

Balance sheet

See full
Cash & equivalents$120.3M+108%
Total debt$237.5M+32.3%
Total equity$435.2M-5.0%
Total assets$886.6M+7.7%

Cash flow

See full
Operating cash flow-$17.6M+4.2%
CapEx$10.7M+58.3%
Free cash flow-$28.3M-12.5%

Valuation

See full
Market cap$376.33M-7.1%
Enterprise value$493.54M-6.3%
P/S0.5×0.0×

Profitability

See full
Gross margin70.7%+3.6pp
Operating margin-5.8%-2.1pp
Net margin-7.3%-2.7pp
FCF margin-9.3%-1.7pp

Returns & leverage

See full
Return on equity-13.4%-4.6pp
Debt / equity0.5×+0.2×
Current ratio2.9×+0.2×

Where this comes from

Reported directly by Orthofix Medical Inc. in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Orthofix Medical Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Orthofix Medical Inc.'s additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Orthofix Medical Inc.'s additional paid-in capital?
Orthofix Medical Inc. (OFIX) reported additional paid-in capital of $820.25M in Q1 2026.
How has Orthofix Medical Inc.'s additional paid-in capital changed year-over-year?
Orthofix Medical Inc.'s additional paid-in capital increased by 4.3% year-over-year, from $786.18M to $820.25M.
What is the long-term trend for Orthofix Medical Inc.'s additional paid-in capital?
Over 5 years (2020 to 2025), Orthofix Medical Inc.'s additional paid-in capital has grown at a 22.7% compound annual growth rate (CAGR), from $292.29M to $813.77M.
What does additional paid-in capital mean?
This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.